Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotides

Date

2016

Authors

Bayik D.
Gursel, I.
Klinman, D. M.

Editor(s)

Advisor

Supervisor

Co-Advisor

Co-Supervisor

Instructor

Source Title

Pharmacological Research

Print ISSN

1043-6618

Electronic ISSN

Publisher

Academic Press

Volume

105

Issue

Pages

216 - 225

Language

English

Journal Title

Journal ISSN

Volume Title

Series

Abstract

Synthetic oligodeoxynucleotides that can down-regulate cellular elements of the immune system have been developed and are being widely studied in preclinical models. These agents vary in sequence, mechanism of action, and cellular target(s) but share the ability to suppress a plethora of inflammatory responses. This work reviews the types of immunosuppressive oligodeoxynucleotide (Sup ODN) and compares their therapeutic activity against diseases characterized by pathologic levels of immune stimulation ranging from autoimmunity to septic shock to cancer (see graphical abstract). The mechanism(s) underlying the efficacy of Sup ODN and the influence size, sequence and nucleotide backbone on function are considered. © Published by Elsevier Ltd.

Course

Other identifiers

Book Title

Citation